Amneal Pharmaceuticals's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Amneal Pharmaceuticals (NYSE:AMRX) is set to release its quarterly earnings report on August 4, 2023. Analysts estimate an earnings per share (EPS) of $0.10. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $3.19 and has seen a 3.28% increase over the last 52-week period.
August 04, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amneal Pharmaceuticals is expected to report an EPS of $0.10 in its upcoming earnings. The stock has seen a 3.28% increase over the last 52 weeks.
The upcoming earnings report is a significant event for Amneal Pharmaceuticals. However, the company's past performance shows a mixed impact on the share price post-earnings release, making it difficult to predict the short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100